Phase I Market Outlook: 2020-2024
$4,460.00 – $8,920.00
Licensing Options
- SINGLE-USER LICENSE
A Single-User License allows access to an individual user.
- ENTERPRISE-WIDE LICENSE
An Enterprise-Wide License allows access to all employees and sites within an organization.
Report Overview
Welcome to ISR’s Phase I Study Trends and Market Outlook (2020-2024) report. The goal of this report is to provide readers with a high-level view of the Phase I clinical development space to illustrate current market dynamics and inform strategic planning. For this report, 137 Phase I decision-makers were surveyed to share their insights into where the Phase I market is now and what changes they expect over the next four years. Current and predicted study spend and outsourcing proportions are key pieces of information with which sponsors and service providers should be familiar. Understanding the service provider selection environment is also critical due to the pervasive use of service providers in the Phase I space; respondents have shared key service provider selection criteria for both complex and simple Phase I studies. Finally, staying on top of trends such as use of challenge trials, diagnostic development, and how companies are responding to the COVID-19 pandemic helps readers stay current with market happenings and plan for what the market is expected to look like in 2024.
What you will learn:
- 4-year examination of the industry’s Phase I market dynamics (e.g. study volume, outsourced spend); including respondent rationale for their predictions
- How outsourced Phase I spend is divided between large CROs, mid-size CROs, dedicated Phase I providers, and AMCs – how this varies by sponsor size and how it is expected to change over time
- Average dollar value of outsourced Phase I studies and the dollar value of studies respondents are comfortable awarding to each provider type
- Which roles have the most responsibility for each of six different decisions related to Phase I study outsourcing
- Evolution of trends in the Phase I market (e.g. diagnostic development, challenge trials, in-silico modeling and simulation, geographic expansion, responses to the COVID-19 pandemic, etc.)
How pharma can use this report:
- Use the predictions of your peers to identify in what types of studies your competition is investing resources and understand how your company’s strategy compares to that of the industry
- Ensure your Phase I outsourcing practices are industry standard or better
How CROs can use this report:
- Utilize this information to ensure your capabilities and capacity are in line with the study types and volume that will be needed in the near future
- Learn which roles are key decision-makers for specific outsourcing-related tasks within sponsor organizations to develop more targeted communications
- Understand the criteria used to select service providers and how the top criteria differ between simple and complex studies
Major Topics:
- Market Dynamics
- Provider Perceptions and Selection
- Trends and Predictions
- Study Data